KDR and systemic lupus erythematosus: However, anti-VEGF activity may not be desirable in lupus, as the renal vasculature is dependent on podocyte-expressed VEGF [63] and NZB/WF1 mice treated with antibodies to VEGFR2 had accelerated nephropathy [64].